Drug: VELCADE Injury: Plasma cell myeloma Quarter: 2016Q3
Total Records: 26 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
122393663 | VELCADE | Plasma cell myeloma | TAKEDA | 33.76 YR | M | 0 | 20160711 | US |
122468932 | VELCADE | Plasma cell myeloma | CELGENE | 47.73 YR | F | 59 KG | 20160826 | US |
122723754 | VELCADE | Plasma cell myeloma | JANSSEN | 0.00 | F | 91 KG | 20160726 | US |
123348872 | VELCADE | Plasma cell myeloma | TAKEDA | 65.45 YR | M | 0 | 20160701 | US |
124068652 | VELCADE | Plasma cell myeloma | TAKEDA | 65.00 YR | F | 0 | 20160719 | CA |
124419833 | VELCADE | Plasma cell myeloma | TAKEDA | 71.33 YR | F | 55 KG | 20160916 | KR |
124781762 | VELCADE | Plasma cell myeloma | TAKEDA | 0.00 | M | 0 | 20160701 | CN |
124953112 | VELCADE | Plasma cell myeloma | TAKEDA | 70.00 YR | F | 0 | 20160721 | US |
125248001 | VELCADE | Plasma cell myeloma | NOVARTIS | 60.00 YR | 0 | 20160704 | JP | |
125308502 | VELCADE | Plasma cell myeloma | TAKEDA | 49.24 YR | F | 0 | 20160922 | US |
125319762 | VELCADE | Plasma cell myeloma | TAKEDA | 0.00 | M | 76 KG | 20160729 | US |
125583683 | VELCADE | Plasma cell myeloma | TAKEDA | 66.00 YR | M | 68 KG | 20160912 | HU |
125656021 | VELCADE | Plasma cell myeloma | CELGENE | 55.63 YR | 0 | 20160718 | US | |
125713521 | VELCADE | Plasma cell myeloma | TAKEDA | 47.75 YR | F | 0 | 20160719 | US |
125795042 | VELCADE | Plasma cell myeloma | TAKEDA | 42.00 YR | M | 0 | 20160811 | US |
125971511 | VELCADE | Plasma cell myeloma | CELGENE | 66.76 YR | 0 | 20160726 | US | |
126090401 | VELCADE | Plasma cell myeloma | NOVARTIS | 80.00 YR | F | 0 | 20160731 | CH |
126345012 | VELCADE | Plasma cell myeloma | CELGENE | 0.00 | M | 0 | 20160825 | JP |
127070051 | VELCADE | Plasma cell myeloma | TAKEDA | 0.00 | M | 68 KG | 20160901 | US |
127105081 | VELCADE | Plasma cell myeloma | NOVARTIS | 60.51 YR | M | 0 | 20160902 | JP |
Total Records: 26 Number of Pages: 2